- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
NAACOS Responds to Senate HELP Committee's Request for Recommendations for Lowering Healthcare Costs
In response to a request for recommendations to help address rising drug costs, the National Association of Accountable Care Organizations (NAACOS) has submitted comments to the Senate Committee on Health, Education, Labor, and Pensions.
In response to a request for recommendations to help address rising drug costs, the National Association of Accountable Care Organizations (NAACOS) has submitted comments to the Senate Committee on Health, Education, Labor, and Pensions. They recommend that Congress continue to ensure that the Medicare Shared Savings Program (MSSP remains strong and encourages robust participation, explaining that Medicare ACO programs like MSSP are the largest value-based payment models in the country and an essential tool in moving toward a value-based healthcare system.
NAACOS also recommended that Congress consider amendments to 42. C.F.R. Part 2, which requires patients to submit written consent prior to the disclosure of their substance use treatment records. According to NAACOS, these requirements are often challenging and they limit whole-person integrated care and care coordination. Read all the comments.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
